4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran hydrochloride

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran hydrochloride
• 英文别名: (2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl)amine hydrochloride；4-amino-2,2-dimethylchroman hydrochloride；2,2-Dimethylchroman-4-amine hydrochloride；2,2-dimethyl-3,4-dihydrochromen-4-amine;hydrochloride
• 化学式: C₁₁H₁₅NO*ClH
• 分子量: 213.707
• InChiKey: OHBAWAXGKXWFAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.67
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  35.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran hydrochloride 生成 4-(N-butylsulfonyl-N-methyl)amino-6-carboxy-2,2-dimethylchroman
  参考文献：
  名称：

  Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them

  摘要：

  磺胺基取代的色苷，其制备方法，其用作药物或诊断的用途，以及包含它们的药物 具有下式I的色苷和下式1a的色苷，其中在权利要求中指示的R(A)、R(B)、R(C)和R(1)到R(8)的含义，非常适合制备用于阻断由环磷酸腺苷单磷酸（cAMP）打开的K+通道的药物；进一步用于制备用于抑制胃酸分泌的药物；用于治疗胃和肠道溃疡，特别是十二指肠的药物；用于治疗反流性食道炎；用于治疗腹泻疾病；用于治疗和预防包括室性和房性心律失常在内的所有类型心律失常；用于控制再入性心律失常和预防由室颤引起的突发心脏死亡。

  公开号：

  US06191164B1
• 作为产物：
  描述：

  2,2-二甲基-苯并二氢吡喃-4-酮 在 aluminum nickel 吡啶 、 盐酸羟胺 作用下， 以 甲醇 、 乙醚 、 氢气 、 乙酸乙酯 为溶剂， 生成 4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran hydrochloride
  参考文献：
  名称：

  Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them

  摘要：

  磺胺基取代的色苷，其制备方法，其用作药物或诊断的用途，以及包含它们的药物 具有下式I的色苷和下式1a的色苷，其中在权利要求中指示的R(A)、R(B)、R(C)和R(1)到R(8)的含义，非常适合制备用于阻断由环磷酸腺苷单磷酸（cAMP）打开的K+通道的药物；进一步用于制备用于抑制胃酸分泌的药物；用于治疗胃和肠道溃疡，特别是十二指肠的药物；用于治疗反流性食道炎；用于治疗腹泻疾病；用于治疗和预防包括室性和房性心律失常在内的所有类型心律失常；用于控制再入性心律失常和预防由室颤引起的突发心脏死亡。

  公开号：

  US06191164B1

文献信息

• [EN] ANTIMALARIAL AGENTS<br/>[FR] AGENTS ANTIPALUDIQUES
  申请人：MERCK SHARP & DOHME

  公开号：WO2021101836A1

  公开（公告）日：2021-05-27

  The present invention provides methods of treating malaria comprising administration of compounds of Formula (I) or a pharmaceutically acceptable salt thereof, to a subject in need thereof, wherein the variables are as defined herein. The invention also provides uses of the compounds of Formula (I), as defined herein, for the possible inhibition of plasmepsin X, plasmepsin IX or plasmepsin X and IX activity, for treating a Plasmodium infection, and for treating malaria. Also provided are methods of treatment further comprising administration of one or more additional anti-malarial compounds.

  本发明提供了治疗疟疾的方法，包括向需要的受试者施用化合物I式或其药用可接受的盐，其中变量如本文所定义。该发明还提供了化合物I式的用途，如本文所定义，用于可能抑制血浆蛋白酶X、血浆蛋白酶IX或血浆蛋白酶X和IX活性，用于治疗疟原虫感染和治疗疟疾。还提供了治疗方法，进一步包括施用一种或多种额外的抗疟疾化合物。
• ANTIMALARIAL AGENTS
  申请人：Merck Sharp & Dohme LLC

  公开号：EP4061375A1

  公开（公告）日：2022-09-28
• CHEMICAL ADDITIVES AND SURFACTANT COMBINATIONS FOR FAVORABLE WETTABILITY ALTERATION AND IMPROVED HYDROCARBON RECOVERY FACTORS
  申请人：Alchemy Sciences, Inc.

  公开号：US20200131431A1

  公开（公告）日：2020-04-30

  A modified treatment fluid includes a first surfactant, wherein the first surfactant is nonionic, cationic, anionic, zwitterionic, or a combination thereof and a wettability altering additive (WEA) that includes an organic salt, an inorganic salt, urea, a urea derivative, a carbamate, ammonia, an amine, a glycol, a glycol ether, an amide, an aldehyde, or a combination thereof. The modified treatment fluid further includes a treatment fluid.
• US6191164B1
  申请人：——

  公开号：US6191164B1

  公开（公告）日：2001-02-20
• Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
  申请人：Hoechst Aktiengesellschaft

  公开号：US06191164B1

  公开（公告）日：2001-02-20

  Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or a diagnostic, and medicament comprising them Chromans of the formula I and of the formula 1a having the meanings R(A), R(B), R(C) and R(1) to R(8) indicated in the claims are outstandingly suitable for preparing a medicament for blocking the K+ channel which is opened by cyclic adenosine monophosphate (cAMP); and further for preparing a medicament for inhibiting gastric acid secretion; for the treatment of ulcers of the stomach and of the intestinal region, in particular of the duodenum, for the treatment of reflux esophagitis, for the treatment of diarrheal illnesses, for the treatment and prevention of all types of arrhythmias including ventricular and supraventricular arrhythmias, and for the control of reentry arrhythmias and for the prevention of sudden heart death as a result of ventricular fibrillation.

  磺胺基取代的色苷，其制备方法，其用作药物或诊断的用途，以及包含它们的药物 具有下式I的色苷和下式1a的色苷，其中在权利要求中指示的R(A)、R(B)、R(C)和R(1)到R(8)的含义，非常适合制备用于阻断由环磷酸腺苷单磷酸（cAMP）打开的K+通道的药物；进一步用于制备用于抑制胃酸分泌的药物；用于治疗胃和肠道溃疡，特别是十二指肠的药物；用于治疗反流性食道炎；用于治疗腹泻疾病；用于治疗和预防包括室性和房性心律失常在内的所有类型心律失常；用于控制再入性心律失常和预防由室颤引起的突发心脏死亡。